InvestorsHub Logo
Followers 44
Posts 10460
Boards Moderated 0
Alias Born 01/13/2016

Re: None

Tuesday, 08/23/2016 7:17:55 AM

Tuesday, August 23, 2016 7:17:55 AM

Post# of 463736
Seeing this valuation..
I keep thinking the bad guys know something I don't..
Maybe they know the PK preliminary trial failed..
from this report, there is no way A2-73 does not go into Human Trials
as the Safety profile will kindly allow for A2-73 in ANY TRIAL!
Maybe they know the 9 month Data shows a downturn in Patients with
ALzheimers? Maybe there is a downturn, it's Alzheiemrs, it's degenerative,
We need to get to Alzheimer's EARLY and use a combination Drug Therapy LATE. Apparently Aricept is not helping with new drug trials..
It looks like People are going to have to make some tough , tough decisions regarding Mono-Therapy with A2-73.
Ladies and Gentleman, if the Safety Profile continues to show the same risk level as taking a sugar pill, then the NeuroProtective Positives of activating the Sigma 1 Ligand co-committant with a muscarinic(Anavex's Muscarinic) is an absolute Blockbuster.
Why we are priced here, is not because the bad people know something we don't ..We are here because the bad people have more money than us and Stock Markets were NEVER DESIGNED to allow BAD PEOPLE to WIN..
Stock Markets were designed to ALLOW GOOD PEOPLE TO WIN..
Let us have faith. Let us pray. Let us demand of the Stock Market
that for which it is designed, for good ideas to flourish.
Anavex is a good idea whose time has come..AnavexNOW!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News